These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Chromosomal abnormalities and neurological outcomes in fetal cerebral ventriculomegaly: a retrospective cohort analysis. Lok WY; Kong CW; Hui SYA; Shi MM; Choy KW; To WK; Leung TY Hong Kong Med J; 2021 Dec; 27(6):428-436. PubMed ID: 34949731 [TBL] [Abstract][Full Text] [Related]
43. Clinical aspects of prenatally detected congenital heart malformations and the yield of chromosomal microarray analysis. Sukenik-Halevy R; Sukenik S; Koifman A; Alpert Y; Hershkovitz R; Levi A; Biron-Shental T Prenat Diagn; 2016 Dec; 36(13):1185-1191. PubMed ID: 27794172 [TBL] [Abstract][Full Text] [Related]
44. Chromosomal microarray analysis in fetuses with high-risk prenatal indications: A retrospective study in China. Luo X; Zhu H; Wang L; Xiao B; Fan Y; Ye H; Ying X; Qiu W; Zhang H; Han L; Gu X; Yu Y; Wang L Taiwan J Obstet Gynecol; 2021 Mar; 60(2):299-304. PubMed ID: 33678331 [TBL] [Abstract][Full Text] [Related]
45. Genetic anomalies in fetuses with tetralogy of Fallot by using high-definition chromosomal microarray analysis. Peng R; Zheng J; Xie HN; He M; Lin MF Cardiovasc Ultrasound; 2019 May; 17(1):8. PubMed ID: 31060568 [TBL] [Abstract][Full Text] [Related]
46. [Application of chromosomal microarray analysis for fetuses with talipes equinovarus]. Guo QL; Fu F; Li R; Jing XY; Lei TY; Han J; Yang X; Zhen L; Pan M; Liao C Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):484-90. PubMed ID: 27465866 [TBL] [Abstract][Full Text] [Related]
48. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Hillman SC; McMullan DJ; Hall G; Togneri FS; James N; Maher EJ; Meller CH; Williams D; Wapner RJ; Maher ER; Kilby MD Ultrasound Obstet Gynecol; 2013 Jun; 41(6):610-20. PubMed ID: 23512800 [TBL] [Abstract][Full Text] [Related]
49. Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mm. Sagi-Dain L; Singer A; Ben Shachar S; Josefsberg Ben Yehoshua S; Feingold-Zadok M; Greenbaum L; Maya I Obstet Gynecol; 2021 Jan; 137(1):126-131. PubMed ID: 33278279 [TBL] [Abstract][Full Text] [Related]
50. Chromosomal microarray findings in pregnancies with an isolated pelvic kidney. Sagi-Dain L; Singer A; Frumkin A; Shalata A; Koifman A; Segel R; Benyamini L; Rienstein S; Kahyat M; Sharony R; Maya I; Ben Shachar S J Perinat Med; 2018 Dec; 47(1):30-34. PubMed ID: 29813032 [TBL] [Abstract][Full Text] [Related]
51. Application of chromosome microarray analysis in prenatal diagnosis. Xia M; Yang X; Fu J; Teng Z; Lv Y; Yu L BMC Pregnancy Childbirth; 2020 Nov; 20(1):696. PubMed ID: 33198662 [TBL] [Abstract][Full Text] [Related]
52. Prenatal diagnosis with chromosome microarray and pregnancy outcomes of fetuses with biliary tract system abnormalities. Qian Y; Xiao L; Zhang L; Hu T; Wang J; Hu R; Liao N; Liu Z; Wang H; Liu S; Zhang Z Prenat Diagn; 2022 Oct; 42(11):1390-1397. PubMed ID: 36068921 [TBL] [Abstract][Full Text] [Related]
53. Polyhydramnios or Excessive Fetal Growth Are Markers for Abnormal Perinatal Outcome in Euglycemic Pregnancies. Crimmins S; Mo C; Nassar Y; Kopelman JN; Turan OM Am J Perinatol; 2018 Jan; 35(2):140-145. PubMed ID: 28838004 [TBL] [Abstract][Full Text] [Related]
54. [Chromosomal microarray analysis for lateral ventriculomegaly in fetus]. Zhang Z; Xie Y; Wu J; Chen X; Lin S; Ji Y; Jiang W; Fang Q; Chen B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):789-92. PubMed ID: 26663049 [TBL] [Abstract][Full Text] [Related]
55. Application of chromosomal microarray analysis in prenatal diagnosis of fetal growth restriction. Zhu H; Lin S; Huang L; He Z; Huang X; Zhou Y; Fang Q; Luo Y Prenat Diagn; 2016 Jul; 36(7):686-92. PubMed ID: 27221052 [TBL] [Abstract][Full Text] [Related]
56. Prenatal diagnosis of posterior fossa anomalies: Additional value of chromosomal microarray analysis in fetuses with cerebellar hypoplasia. Zou Z; Huang L; Lin S; He Z; Zhu H; Zhang Y; Fang Q; Luo Y Prenat Diagn; 2018 Jan; 38(2):91-98. PubMed ID: 29171036 [TBL] [Abstract][Full Text] [Related]
57. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency]. Du L; Xie HN; Zheng J; He M Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122 [No Abstract] [Full Text] [Related]
58. Hypoplastic nasal bone: A potential marker for facial dysmorphism associated with pathogenic copy number variants on microarray. Gu YZ; Nisbet DL; Reidy KL; Palma-Dias R Prenat Diagn; 2019 Jan; 39(2):116-123. PubMed ID: 30578730 [TBL] [Abstract][Full Text] [Related]
59. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies. Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011 [TBL] [Abstract][Full Text] [Related]
60. [Application of chromosomal microarray analysis for fetuses with ventricular septal defects]. Deng Q; Fu F; Li R; Jing X; Lei T; Yang X; Pan M; Zhen L; Han J; Liao C Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):699-704. PubMed ID: 28981937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]